Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TCS a Leader in Life Sciences Digital Services in Europe: Everest Group

Posted On: 2018-10-08 16:38:32

Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been named a Leader in the Everest Group PEAK Matrix™ for life Sciences Digital Services in Europe.1

The report, which analyzed the digital services capabilities of 21 IT service providers specific to the life sciences sector in Europe, highlights TCS' credible digital transformation capabilities with scale and consistency of performance. Also highlighted as a key strength is the company's focus on nextgeneration digital solutions such as the Advanced Drug Development Platform that uses artificial intelligence and IoT for drug development and patient engagement.

"In a Business 4.0™ world, life sciences companies are actively embracing emerging digital technologies across the life sciences value chain to accelerate their growth and transformation agenda," said Debashis Ghosh, President, Life Sciences and Healthcare, TCS. "Our leadership position in Europe with this report and in North America in an earlier report, validate our strong relationships with our customers, contextual knowledge of the different markets we cater to, a consistent successful record with diqital use-cases and proactiveness in driving innovation using the Machine First Delivery Model (MFDM™) for our Life Sciences customers."

TCS partners with leading life sciences companies in leveraging next generation platforms and emerging technologies to drive innovation, gain speed-to-market, and drive internal efficiencies. The company offers a full set of digital transformation services and solutions including advisory services, predictive and prescriptive analytics, genomics research, advanced platform solutions, and cognitive business operations. Early investments in building capabilities in digital technologies in the form of reskilling the workforce, agile workplaces, and intellectual property have helped TCS gain significant scale and depth in the digital space.

TCS' experts in the life sciences domain work closely with solution architects to come up with innovative solutions that use a combination of user-friendly omnichannel front-end technologies, AI, IoT, Big Data analytics, cognitive computing capabilities, robotic process automation, and cloud to reimagine the life sciences value chain. The company's extensive portfolio of intellectual property- such as the Advanced Drug Development platform, Decision Fabric™ for drug safety and pharma, Connected Universe Platform, and Customer Engagement Platform - help customers achieve better speed to market and superior business outcomes.

"The European life sciences market is quite heterogeneous, with different regions and clusters exhibiting specific demand tenets. As their digital initiatives move from pilots to programs, life sciences enterprises in Europe are looking for more strategic engagements around specific themes. Service providers need to address these specific business and technology challenges, in the context of a post-GDPR world to create distinctive market impact. Leveraging its Business 4.0™ framework, TCS is able to stitch end-to-end deals, underpinned by digital technologies, to advance the modernization mandate for European life sciences organizations," said Jimit Arora, Partner, Everest Group.

"Our balanced portfolio of offerings in Life Sciences, continuous investments in intellectual property, domain expertise, contextual knowledge, and depth of digital capabilities, make us a preferred partner for life sciences customers in their Business 4.0™ journey," added Debashis Ghosh.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.2080.1 as compared to the previous close of Rs. 2103.1. The total number of shares traded during the day was 102738 in over 5420 trades.

The stock hit an intraday high of Rs. 2122.9 and intraday low of 2048. The net turnover during the day was Rs. 213219240.

1 Life Sciences Digital in Europe - Service Provider Landscape with Services Peak Matrix™ Assessment 2018: Accelerating Transformation Despite Regulatory Complexity, Everest Group, September 2018


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

IndiaMart InterMESH Ltd Q2 consolidated PAT at Rs. 8.7 crore

Bajaj Finserv Ltd consolidated Q2 PAT jumps to Rs. 1203.72 crores

Jubilant FoodWorks Limited reports EBITDA margin of 23.8%

Kotak Mahindra Bank Consolidated Bank PAT for Q2FY20 Rs. 2,407 cr up 38%

GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended September 30, 2019

Update on US FDA Inspection at Alkem's Bioeguivalcnce Center at Taloja

Lupin receives U.S. FDA approval for Divalproex Sodium ER Tablets USP

PPAP Automotive Ltd Board declares Interim Dividend of Rs. 1 for FY 2019-20

Wendt India Ltd Consolidated Q2 Sales up by 3% & PAT higher by 9%

Granules India Ltd Board declares Second Interim Dividend

Shanthi Gears Limited Revenue up by 19% in Q2

JMC Projects India Ltd secures new orders of Rs. 1,059 Crores

TV Today Network Ltd Board approves Dividend of Rs. 20

Ashoka Buildcon SPV's announce appointed date for NHAI Projects

Solara announces Q2FY20 Financial Results

Newgen Software reports Revenues of Rs 285cr in H1 FY'20, up 11% YoY

Jyothy Labs Ltd announces Q2FY20 consolidated results

Grasim announces formation of JVC - Aditya Birla Power Composites Limited

Elecon Engineering announces Q2FY20 Results

Welspun India Ltd - Emerging businesses gaining traction

AXIS Bank Ltd Q2 consolidated net loss at Rs. 18.14 crore

GlaxoSmithKline Pharmaceuticals Ltd Q2 consolidated net profit at Rs. 502.75 crores

Wendt India Ltd Q2 consolidated net profit climbs to Rs. 5.01 crore

Subros Ltd consolidated Q2 net profit drops to Rs. 13.35 crore

Auro Laboratories Ltd posts net profit of Rs. 1.44 crore

Indiabulls Ventures Ltd Q2 consolidated PAT at Rs. 126.77 crores

IMFA Q2 loss at Rs. 33.62 crores

Jubilant FoodWorks Ltd Q2 consolidated net profit at Rs. 73.42 crore

Premier Polyfilm Ltd Q2 net profit at Rs. 1.04 crore

PPAP Automotive Ltd Q2 PAT lower at Rs. 4.03 crore

PSP Projects Ltd Q2 consolidated net profit higher at Rs. 32.46 crore

Kotak Mahindra Bank Ltd Q2 consolidated PAT soars to Rs. 2407.25 crores

Jyothy Labs Ltd Q2 consolidated PAT up at Rs. 53.59 crores

TV Today Network Ltd Q2 consolidated PAT at Rs. 23 crore

Integra Engineering India Ltd posts net profit of Rs. 2.05 crore

Ultracab India Ltd Q2 net profit at Rs. 0.21 crore

Solara Active Pharma Sciences Ltd Q2 consolidated PAT at Rs. 28.91 crores

Thomas Cook India Opens new outlet at LG-18, DB Mall to cater to strong demand

Granules India Ltd Q2 consolidated net profit higher at Rs. 95.79 crores

Lincoln Pharmaceuticals Limited receives a Patent for Diclofenac Rectal Spray

BHEL commissions 800 MW supercritical thermal power plant in Gujarat

Nandan Nilekani, Chairman of Infosys Limited on whistleblower complaints

Bajaj Finance Ltd reports highest ever quarterly consolidated profit of Rs. 1,506 crore

Rane Brake Lining Limited announces Q2 FY2019-20 results

Aleor Dermaceuticals receives USFDA Approval for Clobetasol Propionate Topical Solution USP, 0.05%

Do not waste! Respect nature - Japan's 'Mottainai Grandma' tells school children in Haryana

Asahi Songwon Colors to form JV for manufacturing AZO pigments in India

Royal Orchid & Regenta Hotels Launch 2 New Properties

AU Bank appoints Prof. Mr. M.S. Sriram, Inclusive Finance Expert and Mr. Pushpinder Singh, Banking Technology Expert as Independent Director

Bajaj Finance Ltd Q2 consolidated PAT climbs to Rs. 1506.29 crores







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019